MS Active Source
MS Treatment Can Make a Difference.
Multiple Sclerosis Treatment can slow the progression of your disease and reduce the number of relapses. Learn how to choose a multiple sclerosis treatment that's right for you.

 

 

 

National MS Society
The National MS Society is committed to building a movement by and for people with MS that will move us closer to a world free of this disease.

 

 

 

Mayo Clinic
Multiple sclerosis (MS) is a chronic, potentially debilitating disease that affects your central nervous system, which is made up of your brain and spinal cord. Multiple sclerosis is widely believed to be an autoimmune disease, a condition in which your immune system attacks components of your body as if they're foreign.

 

 

National Institute of Neurological Disorders and Stroke
An unpredictable disease of the central nervous system, multiple sclerosis (MS) can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted. Many investigators believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault. Such assaults may be linked to an unknown environmental trigger, perhaps a virus.

 

AVONEX
AVONEX has been available for over 10 years, and since 1998 it's the #1 prescribed MS treatment* in the U.S. and worldwide for many reasons, including:

• •AVONEX is effective at treating both relapses and physical disability
• •AVONEX offers once-a-week convenience

AVONEX is prescribed to treat relapsing forms of multiple sclerosis, to decrease the number of flare-ups and slow the occurrence of some of the physical disability common in people with MS.

TYSABRI
On June 5, 2006, the US Food and Drug Administration (FDA) approved a Supplemental Biologics License Application (sBLA) for the reintroduction of TYSABRI® (natalizumab) as monotherapy treatment for relapsing forms of multiple sclerosis (MS). We are pleased to be able to once again offer TYSABRI for appropriate MS patients.

 

 

COPAXONE
Living with multiple sclerosis may change the way you think about life, but you’re taking a positive step by considering your relapsing-remitting MS (RRMS) treatment options. Committing to multiple sclerosis therapy can help you effectively manage your RRMS, and COPAXONE® has the proven track record you may be looking for in your treatment choice.

 

 

BETACERON
BETASERON® (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

 

 

MS LifeLines
Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence of some of the physical disability that is common in people with MS. Rebif is not approved for the treatment of chronic progressive multiple sclerosis. Rebif is available by prescription only in 22 mcg and 44 mcg pre-filled syringes and a titration pack.